EULAR: Updated scleroderma guidance focuses on new treatments, approaches

Author: Sara Freeman
Date Published: June-2015
Source: PM360

ROME (FRONTLINE MEDICAL NEWS) – Updated expert recommendations from the European League Against Rheumatism for the treatment of systemic sclerosis will focus on several new treatment options, although the use of biologic agents is not included in detail because there are still too few data on these drugs to give firm guidance on their use. The EULAR Scleroderma Trials and Research group (EUSTAR) recommendations for the treatment of scleroderma were first published 6 years ago ( Ann. Rheum. Dis. 2009;68:620-8 ) and considered data through December 2006. “Since then, a number of new drugs have become available and new and important information has been published concerning treatments already known before,” said Dr. Otylia Kowal-Bielecka of the Medical University of Bialystok, Poland, who discussed some of the main highlights of the revised recommendations (Ann. Rheum. Dis. 2015;74:90-1) at the European Congress of Rheumatology.